Literature DB >> 16791023

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.

Sabelle Jallow1, Steve Kaye, Abraham Alabi, Akum Aveika, Ramu Sarge-Njie, Saihou Sabally, Tumani Corrah, Hilton Whittle, Guido Vanham, Sarah Rowland-Jones, Wouter Janssens, Samuel J McConkey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16791023     DOI： 10.1097/01.aids.0000233582.64467.8e

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  20 in total

Review 1.  Antiretroviral drug resistance in human immunodeficiency virus type 2.

Authors:  Michel L Ntemgwa; Thomas d'Aquin Toni; Bluma G Brenner; Ricardo J Camacho; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

2.  First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Authors:  Julia Drylewicz; Serge Eholie; Moussa Maiga; Djimon Marcel Zannou; Papa Salif Sow; Didier K Ekouevi; Kevin Peterson; Emmanuel Bissagnene; François Dabis; Rodolphe Thiébaut
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

3.  MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.

Authors:  Vincent H Wu; Robert A Smith; Sara Masoum; Dana N Raugi; Selly Ba; Moussa Seydi; Jay A Grobler; Geoffrey S Gottlieb
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

4.  Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.

Authors:  Ilona P Deuzing; Charlotte Charpentier; David W Wright; Sophie Matheron; Jack Paton; Dineke Frentz; David A van de Vijver; Peter V Coveney; Diane Descamps; Charles A B Boucher; Nancy Beerens
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

5.  Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Authors:  Geoffrey S Gottlieb; Ndeye Mery Dia Badiane; Stephen E Hawes; Louise Fortes; Macoumba Toure; Cheikh T Ndour; Alison K Starling; Fatou Traore; Fatima Sall; Kim G Wong; Stephen L Cherne; Donovan J Anderson; Stefanie A Dye; Robert A Smith; James I Mullins; Nancy B Kiviat; Papa Salif Sow
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

6.  Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance.

Authors:  Robert A Smith; Donovan J Anderson; Crystal L Pyrak; Bradley D Preston; Geoffrey S Gottlieb
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

7.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

8.  Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2.

Authors:  H Syed Iqbal; P Balakrishnan; K G Murugavel; Solomon Suniti
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.

Authors:  Philip L Tzou; Diane Descamps; Soo-Yon Rhee; Dana N Raugi; Charlotte Charpentier; Nuno Taveira; Robert A Smith; Vicente Soriano; Carmen de Mendoza; Susan P Holmes; Geoffrey S Gottlieb; Robert W Shafer
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

10.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Authors:  Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun-Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.